View source for Chemogenomics

'''Chemogenomics''' is the study of [[genomics|genomic]] responses to [[chemical compound]]s. The goal is the rapid identification of novel [[drug]]s and [[drug target]]s, embracing multiple early phase [[drug development|drug discovery]] technologies ranging from [[drug target identification|target identification]] and [[drug target validation|validation]], through compound design and [[chemical synthesis]], to biological testing and [[ADME]] profiling.

==See also==
*[[Genomics]]
**[[Structural genomics]]
** [[Pharmacogenetics]]
**[[Pharmacogenomics]]
** [[Toxicogenomics]]
* [[Bioinformatics]]
* [[Cheminformatics]]
** [[Computational chemistry]]
** [[Molecular modelling]]
** [[QSAR]]
* [[Proteochemometrics]]

==References==
* ''Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective'', H. Kubinyi (Editor), G. Müller (Editor), R. Mannhold (Series Editor), G. Folkers (Series Editor), Wiley-VCH, '''2004'''.ISBN 3-527-30987-X

==External links==
*[http://www.kubinyi.de/dd-03.pdf Kubinyi's slides]

{{Medicinal chemistry}}
{{genomics-footer}}

{{pharma-stub}}

[[Category:Computational chemistry]]
[[Category:Genomics]]
[[Category:Omics]]
[[Category:Pharmacology]]
[[Category:Pharmaceutical industry]]
[[Category:Cheminformatics]]

[[de:Chemische Genetik]]
[[fr:Chimiogénomique]]
[[ko:화학유전체학]]
[[Category:2Fix]]